Cirello Valentina
Fixed-term Research Fellow A
Scientific-Disciplinary Sector
MEDS-08/A - Endocrinology and Metabolism
Scientific-Disciplinary Group/Competition Sector
06/MEDS-08 - ENDOCRINOLOGIA, NEFROLOGIA E SCIENZE DELL'ALIMENTAZIONE E DEL BENESSERE
Research fields and competencies
Contacts
Workplace
University email address
Teaching - Programme courses
Postgraduate programmes
A.Y. 2024/2025
Doctoral programme (PhD)
A.Y. 2023/2024
Doctoral programme (PhD)
Postgraduate Schools - Medicine, Healthcare, Dental Medicine
- Endocrinologia (Postgraduate School of Medical Genetics Reserved for Non-Doctors )
- Endocrinologia (Postgraduate School of Medical Genetics )
- Endocrinologia 3 (Postgraduate School of Endocrinology and Metabolism)
A.Y. 2022/2023
Doctoral programme (PhD)
Postgraduate Schools - Medicine, Healthcare, Dental Medicine
- Endocrinologia (Postgraduate School of Medical Genetics Reserved for Non-Doctors )
- Endocrinologia (Postgraduate School of Medical Genetics )
- Endocrinologia 3 (Postgraduate School of Endocrinology and Metabolism)
Research
Publications
-
TP53 Alterations Associate with Poor Response to Lenvatinib in Patients with Advanced Thyroid Cancer / V. Cirello, C. Colombo, D. Tosi, A. Manzo, M.O. Borghi, U. Gianelli, G. Gazzano, S. Ferrero, G. Dionigi, L. Persani, L. Fugazzola. - In: THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM. - ISSN 0021-972X. - (2025), pp. dgaf056.1-dgaf056.13. [Epub ahead of print] [10.1210/clinem/dgaf056]
-
Poorly differentiated thyroid carcinoma: molecular, clinico-pathological hallmarks and therapeutic perspectives / V. Cirello, C. Gambale, A.V. Nikitski, C. Masaki, J. Roque, C. Colombo. - In: PANMINERVA MEDICA. - ISSN 0031-0808. - 66:2(2024 Jun), pp. 155-173. [10.23736/s0031-0808.23.05040-1]
-
Thyroid cancer and endocrine disruptive chemicals: a case–control study on per-fluoroalkyl substances and other persistent organic pollutants / V. Cirello, M. Lugaresi, C. Moneta, P. Dufour, A. Manzo, E. Carbone, C. Colombo, L. Fugazzola, C. Charlier, C. Pirard. - 13:3(2024), pp. e230192.1-e230192.15. [10.1530/etj-23-0192]
-
Targeting the DNA damage response kinase Chk1 in TP53-mutated aggressive thyroid cancers: in vitro studies / A. Manzo, V. Cirello, E.S. Grassi, C. Colombo, L. Fugazzola, L. Persani. ((Intervento presentato al 7. convegno BioMeTra Workshop tenutosi a Milano nel 2023.
-
Inactivating mutations of TP53 and resistence to tyrosine-kinase inhibitors in patients affected with aggressive thyroid cancer / V. Cirello, C. Colombo, A. Manzo, D. Tosi, U. Gianelli, G. Gazzano, S. Ferrero, L. Persani, L. Fugazzola. ((Intervento presentato al 45. convegno Annual Meeting of the European Thyroid Association : 9–12 September tenutosi a Milano nel 2023.